LANOLIN, PETROLATUM

LANOLIN, PETROLATUM was reported 248 times

LANOLIN, PETROLATUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INCREASED ANTEROPOSTERIOR CHEST DIAMETER 1 0.1250
1 MONONUCLEAR CELL COUNT INCREASED 1 0.0909
2 URINE URIC ACID ABNORMAL 1 0.0556
3 HYPOXIC ISCHAEMIC ENCEPHALOPATHY NEONATAL 1 0.0179
4 PRURITUS ANI 1 0.0169
5 CITROBACTER TEST POSITIVE 1 0.0152
6 RECTAL CANCER RECURRENT 1 0.0118
7 ENTEROCELE 1 0.0099
8 OLIGODENDROGLIOMA 1 0.0083
9 CARDIAC ARREST NEONATAL 1 0.0072
10 NEONATAL RESPIRATORY ARREST 1 0.0068
11 NEONATAL RESPIRATORY ACIDOSIS 1 0.0066
12 HYPERBARIC OXYGEN THERAPY 1 0.0060
13 MALIGNANT NEOPLASM OF SPINAL CORD 1 0.0055
14 PYELONEPHRITIS CHRONIC 1 0.0053
15 RED CELL DISTRIBUTION WIDTH ABNORMAL 1 0.0053
16 CD8 LYMPHOCYTES DECREASED 1 0.0050
17 PORTAL FIBROSIS 1 0.0047
18 PROTEUS TEST POSITIVE 1 0.0045
19 BIOPSY LIVER ABNORMAL 1 0.0033
20 GENITAL PRURITUS FEMALE 1 0.0031
21 DISTAL INTESTINAL OBSTRUCTION SYNDROME 1 0.0030
22 HYPOCHROMIC ANAEMIA 3 0.0030
23 CUBITAL TUNNEL SYNDROME 1 0.0029
24 FAT EMBOLISM 1 0.0028
25 SKIN TURGOR DECREASED 1 0.0026
26 HEMIPARAESTHESIA 1 0.0026
27 NECROTISING ENTEROCOLITIS NEONATAL 1 0.0025
28 EXPOSURE VIA EYE CONTACT 1 0.0024
29 NAIL BED DISORDER 1 0.0023
30 COLONOSCOPY ABNORMAL 1 0.0023
31 BONE DEBRIDEMENT 1 0.0021
32 CHRONIC MYELOID LEUKAEMIA RECURRENT 1 0.0018
33 LUNG INFECTION PSEUDOMONAL 1 0.0018
34 VESTIBULAR DISORDER 2 0.0016
35 BLOOD CORTISOL DECREASED 1 0.0016
36 ABDOMINAL WALL ABSCESS 1 0.0015
37 MACULAR FIBROSIS 1 0.0015
38 T-LYMPHOCYTE COUNT DECREASED 1 0.0015
39 SPUTUM INCREASED 3 0.0014
40 NODAL RHYTHM 2 0.0014
41 CHOLANGITIS ACUTE 1 0.0013
42 TRACHEITIS 1 0.0013
43 ADRENAL SUPPRESSION 1 0.0012
44 OVARIAN CANCER METASTATIC 1 0.0012
45 SPINAL CORD NEOPLASM 1 0.0011
46 ANAEMIA OF CHRONIC DISEASE 1 0.0011
47 ACTINOMYCOSIS 1 0.0010
48 EYELID PAIN 2 0.0010
49 GALLBLADDER ENLARGEMENT 1 0.0009
50 DRUG EXPOSURE VIA BREAST MILK 1 0.0009
51 FACIAL SPASM 1 0.0009
52 MYOCARDIAL INJURY 1 0.0009
53 LYMPHOCYTE COUNT ABNORMAL 1 0.0009
54 BLOODY DISCHARGE 1 0.0009
55 PRIAPISM 3 0.0009
56 APPLICATION SITE EROSION 1 0.0008
57 ACROCHORDON 1 0.0008
58 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 4 0.0007
59 B-LYMPHOCYTE COUNT DECREASED 1 0.0007
60 NASAL DISCHARGE DISCOLOURATION 1 0.0007
61 RHONCHI 1 0.0007
62 PRECANCEROUS CELLS PRESENT 1 0.0007
63 RED BLOOD CELL COUNT ABNORMAL 1 0.0007
64 COCCYDYNIA 1 0.0007
65 SINUS ARREST 1 0.0006
66 OPTIC NERVE DISORDER 1 0.0006
67 BILIARY DYSKINESIA 1 0.0006
68 BLOOD CHLORIDE INCREASED 1 0.0006
69 TREATMENT DELAYED 1 0.0006
70 OTORRHOEA 1 0.0006
71 KYPHOSIS 1 0.0006
72 PANCREATIC FAILURE 1 0.0006
73 HISTOPLASMOSIS 1 0.0006
74 FIBRIN D DIMER INCREASED 2 0.0006
75 DRUG WITHDRAWAL CONVULSIONS 1 0.0006
76 PARAPARESIS 1 0.0006
77 UTERINE POLYP 1 0.0006
78 MONOCYTE COUNT INCREASED 2 0.0006
79 ESSENTIAL HYPERTENSION 1 0.0005
80 SINUS NODE DYSFUNCTION 1 0.0005
81 BLOOD IRON INCREASED 1 0.0005
82 JAUNDICE NEONATAL 1 0.0005
83 PERONEAL NERVE PALSY 3 0.0005
84 HYPERCOAGULATION 1 0.0005
85 RENAL HAEMORRHAGE 1 0.0005
86 CHOLANGITIS SCLEROSING 1 0.0005
87 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
88 CD4 LYMPHOCYTES DECREASED 1 0.0005
89 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
90 PULMONARY FUNCTION TEST DECREASED 2 0.0005
91 LARGE INTESTINAL OBSTRUCTION 1 0.0004
92 GASTRIC POLYPS 1 0.0004
93 ABNORMAL LOSS OF WEIGHT 3 0.0004
94 NEUROLOGICAL DECOMPENSATION 1 0.0004
95 SINUS OPERATION 1 0.0004
96 ACUTE PSYCHOSIS 1 0.0004
97 FOOT OPERATION 2 0.0004
98 EYELID IRRITATION 1 0.0004
99 VASODILATATION 1 0.0004
100 ENDODONTIC PROCEDURE 1 0.0004
101 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
102 CANCER PAIN 1 0.0004
103 SERUM FERRITIN INCREASED 2 0.0004
104 ULCERATIVE KERATITIS 1 0.0004
105 SERUM SICKNESS 1 0.0004
106 HEART VALVE INCOMPETENCE 1 0.0003
107 CREPITATIONS 1 0.0003
108 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
109 RECTAL CANCER 1 0.0003
110 PORTAL HYPERTENSION 1 0.0003
111 INFUSION SITE PRURITUS 1 0.0003
112 C-REACTIVE PROTEIN ABNORMAL 2 0.0003
113 FACET JOINT SYNDROME 1 0.0003
114 NEOPLASM RECURRENCE 1 0.0003
115 HEPATIC FIBROSIS 1 0.0003
116 DIFFICULTY IN WALKING 1 0.0003
117 AUTOIMMUNE HEPATITIS 2 0.0003
118 THROMBOPHLEBITIS 1 0.0003
119 APPENDICECTOMY 1 0.0003
120 NEUTROPENIC SEPSIS 2 0.0003
121 DENTAL CARIES 3 0.0003
122 WOUND HAEMORRHAGE 1 0.0003
123 COMMUNICATION DISORDER 1 0.0003
124 THYROID MASS 1 0.0003
125 PRODUCT USE COMPLAINT 4 0.0003
126 SKIN PAPILLOMA 1 0.0002
127 STENT PLACEMENT 2 0.0002
128 PERIPHERAL VENOUS DISEASE 1 0.0002
129 PERIPHERAL ISCHAEMIA 1 0.0002
130 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
131 SECOND PRIMARY MALIGNANCY 2 0.0002
132 ONYCHOMADESIS 1 0.0002
133 MONOPLEGIA 1 0.0002
134 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
135 MELANOCYTIC NAEVUS 1 0.0002
136 ONYCHOMYCOSIS 1 0.0002
137 ABDOMINAL ABSCESS 1 0.0002
138 RHEUMATIC FEVER 1 0.0002
139 OROPHARYNGEAL DISCOMFORT 2 0.0002
140 EAR DISORDER 1 0.0002
141 ISCHAEMIA 1 0.0002
142 HYPOVOLAEMIC SHOCK 1 0.0002
143 APHAGIA 1 0.0002
144 FINGER DEFORMITY 1 0.0002
145 STAPHYLOCOCCAL SEPSIS 1 0.0002
146 OVARIAN CYST 2 0.0002
147 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
148 KLEBSIELLA INFECTION 1 0.0002
149 TOE AMPUTATION 1 0.0002
150 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
151 CACHEXIA 1 0.0002
152 SKIN NECROSIS 1 0.0002
153 MALABSORPTION 1 0.0002
154 FOOD POISONING 1 0.0002
155 PRODUCT RESIDUE PRESENT 1 0.0002
156 GINGIVITIS 1 0.0002
157 STRESS FRACTURE 1 0.0002
158 NORMAL NEWBORN 1 0.0002
159 MACULAR OEDEMA 1 0.0002
160 PRODUCT LEAKAGE 1 0.0002
161 CARDIAC VALVE DISEASE 1 0.0002
162 EXERCISE TOLERANCE DECREASED 1 0.0002
163 RALES 1 0.0002
164 PRODUCT LABEL CONFUSION 1 0.0002
165 DECREASED INTEREST 1 0.0002
166 DRUG ABUSER 1 0.0002
167 BLEPHAROSPASM 1 0.0002
168 PHOTOPSIA 1 0.0002
169 SCREAMING 1 0.0002
170 ENTERITIS 1 0.0002
171 POOR QUALITY DRUG ADMINISTERED 1 0.0002
172 BREAST CANCER STAGE III 1 0.0002
173 APPLICATION SITE VESICLES 1 0.0002
174 PLATELET COUNT INCREASED 2 0.0002
175 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
176 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
177 BRONCHIECTASIS 1 0.0001
178 PRODUCT LABEL ISSUE 1 0.0001
179 CORONARY ARTERY OCCLUSION 2 0.0001
180 LYMPHOEDEMA 1 0.0001
181 LARGE INTESTINE POLYP 1 0.0001
182 APHONIA 2 0.0001
183 SEASONAL ALLERGY 2 0.0001
184 DIVERTICULUM 1 0.0001
185 RED BLOOD CELL COUNT DECREASED 4 0.0001
186 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1 0.0001
187 VISUAL FIELD DEFECT 1 0.0001
188 APPLICATION SITE PAIN 3 0.0001
189 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
190 DUODENAL ULCER PERFORATION 1 0.0001
191 MUSCULOSKELETAL PAIN 7 0.0001
192 HYDRONEPHROSIS 1 0.0001
193 RENAL FAILURE CHRONIC 1 0.0001
194 HAEMOLYSIS 1 0.0001
195 MUSCULOSKELETAL CHEST PAIN 2 0.0001
196 ACUTE MYELOID LEUKAEMIA 2 0.0001
197 AFFECTIVE DISORDER 1 0.0001
198 DRUG SCREEN POSITIVE 1 0.0001
199 RESPIRATORY TRACT CONGESTION 2 0.0001
200 OBESITY 2 0.0001
201 SENSORY LOSS 1 0.0001
202 DECUBITUS ULCER 1 0.0001
203 HICCUPS 1 0.0001
204 MENSTRUAL DISORDER 1 0.0001
205 MUSCLE INJURY 1 0.0001
206 LIVE BIRTH 1 0.0001
207 PRODUCT CONTAINER ISSUE 1 0.0001
208 CARDIAC OPERATION 1 0.0001
209 BLOOD MAGNESIUM DECREASED 1 0.0001
210 MUSCLE STRAIN 1 0.0001
211 PYELONEPHRITIS 1 0.0001
212 NAIL DISORDER 1 0.0001
213 GRIP STRENGTH DECREASED 1 0.0001
214 COLD SWEAT 2 0.0001
215 HAEMOLYTIC ANAEMIA 1 0.0001
216 HAEMARTHROSIS 1 0.0001
217 ANAL INCONTINENCE 1 0.0001
218 LIP DRY 1 0.0001
219 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
220 RETINAL DETACHMENT 1 0.0001
221 NERVE COMPRESSION 1 0.0001
222 LACERATION 1 0.0001
223 FOOT FRACTURE 2 0.0001
224 SPUTUM DISCOLOURED 1 0.0001
225 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
226 POST PROCEDURAL COMPLICATION 2 0.0001
227 HYPERCHOLESTEROLAEMIA 1 0.0001
228 VITAMIN D DEFICIENCY 1 0.0001
229 SKIN FISSURES 2 0.0001
230 COELIAC DISEASE 1 0.0001
231 HEPATOMEGALY 1 0.0001
232 VITREOUS FLOATERS 1 0.0001
233 HOSPICE CARE 1 0.0001
234 LIGAMENT SPRAIN 1 0.0001
235 BLADDER DISORDER 1 0.0001
236 RESPIRATORY DISORDER 3 0.0001
237 HYPOTONIA 1 0.0001
238 BLOOD POTASSIUM DECREASED 3 0.0001
239 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
240 EYELID PTOSIS 1 0.0001
241 TOOTH ABSCESS 1 0.0001
242 SLUGGISHNESS 1 0.0001
243 NEUTROPHIL COUNT INCREASED 1 0.0001
244 HELICOBACTER INFECTION 1 0.0001
245 TEMPERATURE INTOLERANCE 1 0.0001
246 HYPERBILIRUBINAEMIA 1 0.0001
247 VENTRICULAR EXTRASYSTOLES 1 0.0001
248 EYE DISCHARGE 1 0.0001
249 PRODUCT ODOUR ABNORMAL 1 0.0001
250 FOLLICULITIS 1 0.0001
251 INJECTION SITE DISCOMFORT 1 0.0001
252 INCONTINENCE 1 0.0001
253 JOINT DISLOCATION 1 0.0001
254 NIGHT SWEATS 3 0.0001
255 FAECES DISCOLOURED 2 0.0001
256 BACK INJURY 1 0.0001
257 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
258 WOUND INFECTION 1 0.0001
259 GASTROINTESTINAL PAIN 1 0.0001
260 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
261 OCULAR DISCOMFORT 1 0.0001
262 EYE PAIN 5 0.0001
263 STATUS EPILEPTICUS 1 0.0001
264 INTERNAL HAEMORRHAGE 1 0.0001
265 SPLENOMEGALY 1 0.0001
266 SPINAL PAIN 1 0.0001
267 WHEEZING 5 0.0001
268 HYPERLIPIDAEMIA 1 0.0001
269 HEPATITIS C 1 0.0001
270 BURSITIS 1 0.0001
271 SCHIZOPHRENIA 1 0.0001
272 NO THERAPEUTIC RESPONSE 1 0.0001
273 SMALL INTESTINAL OBSTRUCTION 1 0.0001
274 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
275 ILEUS 1 0.0001
276 APPLICATION SITE IRRITATION 1 0.0001
277 TOOTH EXTRACTION 1 0.0001
278 PNEUMONIA ASPIRATION 2 0.0001
279 PEMPHIGUS 1 0.0001
280 SECRETION DISCHARGE 1 0.0001
281 COLITIS 3 0.0001
282 ANOREXIA 1 0.0001
283 SPEECH DISORDER 4 0.0001
284 HAND DEFORMITY 1 0.0001
285 DYSMENORRHOEA 1 0.0001
286 ADVERSE REACTION 1 0.0001
287 JOINT RANGE OF MOTION DECREASED 1 0.0001
288 NEUTROPHIL COUNT DECREASED 3 0.0001
289 ORAL DISCOMFORT 1 0.0001
290 BLOOD TEST ABNORMAL 1 0.0001
291 DEVICE OCCLUSION 1 0.0001
292 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
293 PAIN IN JAW 2 0.0001
294 HEPATOCELLULAR INJURY 1 0.0001
295 MUSCULAR WEAKNESS 8 0.0001
296 SUBDURAL HAEMATOMA 1 0.0001
297 HYPERSOMNIA 2 0.0001
298 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
299 HAEMOGLOBIN DECREASED 7 0.0001
300 SKIN HAEMORRHAGE 1 0.0001
301 HAEMORRHAGE INTRACRANIAL 1 0.0001
302 HYPOAESTHESIA ORAL 1 0.0001
303 FEELING HOT 4 0.0001
304 LUNG INFECTION 1 0.0001
305 DRUG-INDUCED LIVER INJURY 2 0.0001
306 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
307 SENSORY DISTURBANCE 1 0.0001
308 MUSCLE TIGHTNESS 1 0.0001
309 INFUSION RELATED REACTION 4 0.0001
310 EXPIRED PRODUCT ADMINISTERED 2 0.0001
311 DEHYDRATION 8 0.0001
312 URINARY RETENTION 2 0.0001
313 PERICARDITIS 1 0.0001
314 GASTRIC DISORDER 2 0.0001
315 DELIRIUM 2 0.0001
316 SYRINGE ISSUE 1 0.0001
317 BRADYCARDIA 3 0.0001
318 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
319 INSOMNIA 15 0.0001
320 GALLBLADDER DISORDER 1 0.0001
321 SYNOVITIS 1 0.0001
322 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
323 TOOTHACHE 1 0.0001
324 OSTEOMYELITIS 1 0.0001
325 C-REACTIVE PROTEIN INCREASED 2 0.0001
326 BONE DISORDER 1 0.0001
327 DYSURIA 2 0.0001
328 BLOOD GLUCOSE ABNORMAL 1 0.0001
329 BRONCHITIS 4 0.0001
330 EYE SWELLING 2 0.0001
331 NECK PAIN 3 0.0001
332 MIDDLE INSOMNIA 1 0.0001
333 HEPATIC CIRRHOSIS 1 0.0001
334 PHOTOPHOBIA 1 0.0001
335 INTESTINAL OBSTRUCTION 2 0.0001
336 HYPOCALCAEMIA 1 0.0001
337 FRACTURE 1 0.0001
338 PULMONARY EMBOLISM 5 0.0001
339 SLEEP APNOEA SYNDROME 1 0.0001
340 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
341 PRODUCT SUBSTITUTION ISSUE 3 0.0001
342 CHOLESTASIS 1 0.0001
343 HERNIA 1 0.0001
344 EAR PAIN 1 0.0001
345 VISION BLURRED 7 0.0001
346 MENORRHAGIA 1 0.0001
347 DYSPEPSIA 5 0.0001
348 SINUS DISORDER 1 0.0001
349 ABNORMAL BEHAVIOUR 2 0.0001
350 DISORIENTATION 2 0.0001
351 FULL BLOOD COUNT DECREASED 1 0.0000
352 PRODUCT PHYSICAL ISSUE 1 0.0000
353 PRODUCT ADMINISTRATION ERROR 1 0.0000
354 TASTE DISORDER 1 0.0000
355 PSORIATIC ARTHROPATHY 2 0.0000
356 FLUSHING 5 0.0000
357 TOOTH LOSS 1 0.0000
358 POLLAKIURIA 2 0.0000
359 INTENTIONAL DRUG MISUSE 1 0.0000
360 DERMATITIS 1 0.0000
361 RETCHING 1 0.0000
362 JOINT INJURY 1 0.0000
363 IRRITABLE BOWEL SYNDROME 1 0.0000
364 LIVER FUNCTION TEST INCREASED 1 0.0000
365 POOR QUALITY SLEEP 1 0.0000
366 BALANCE DISORDER 4 0.0000
367 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
368 MUSCULOSKELETAL STIFFNESS 4 0.0000
369 MELAENA 1 0.0000
370 BLOOD PRESSURE DECREASED 3 0.0000
371 LIVER DISORDER 2 0.0000
372 TRANSAMINASES INCREASED 1 0.0000
373 TOOTH DISORDER 1 0.0000
374 GLOSSODYNIA 1 0.0000
375 THROAT IRRITATION 2 0.0000
376 PANCREATITIS ACUTE 1 0.0000
377 CHROMATURIA 1 0.0000
378 APPLICATION SITE PRURITUS 1 0.0000
379 PRODUCT AVAILABILITY ISSUE 1 0.0000
380 MEMORY IMPAIRMENT 6 0.0000
381 INJECTION SITE REACTION 3 0.0000
382 MUSCLE TWITCHING 1 0.0000
383 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
384 COGNITIVE DISORDER 2 0.0000
385 INJURY 3 0.0000
386 PRODUCTIVE COUGH 2 0.0000
387 MOBILITY DECREASED 3 0.0000
388 FIBROMYALGIA 1 0.0000
389 PRESYNCOPE 1 0.0000
390 NEURALGIA 1 0.0000
391 LIVER INJURY 1 0.0000
392 ENCEPHALOPATHY 1 0.0000
393 ABASIA 1 0.0000
394 AGEUSIA 1 0.0000
395 CELLULITIS 2 0.0000
396 HEPATITIS 1 0.0000
397 SINUSITIS 4 0.0000
398 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
399 RASH GENERALISED 1 0.0000
400 HAEMATOMA 1 0.0000
401 ABDOMINAL DISTENSION 4 0.0000
402 DEAFNESS 1 0.0000
403 GASTRITIS 1 0.0000
404 PYREXIA 13 0.0000
405 PAIN OF SKIN 1 0.0000
406 DISTURBANCE IN ATTENTION 2 0.0000
407 FREQUENT BOWEL MOVEMENTS 1 0.0000
408 BLOOD BILIRUBIN INCREASED 1 0.0000
409 ANAEMIA 7 0.0000
410 HAEMATOCHEZIA 2 0.0000
411 DIVERTICULITIS 1 0.0000
412 PROCEDURAL PAIN 1 0.0000
413 ARTHROPATHY 2 0.0000
414 FEELING COLD 1 0.0000
415 INFLUENZA 4 0.0000
416 HAEMOPTYSIS 1 0.0000
417 URTICARIA 6 0.0000
418 PANCYTOPENIA 2 0.0000
419 WOUND 1 0.0000
420 BLISTER 2 0.0000
421 OXYGEN SATURATION DECREASED 2 0.0000
422 HYPONATRAEMIA 2 0.0000
423 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
424 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
425 ANGINA PECTORIS 1 0.0000
426 DECREASED APPETITE 8 0.0000
427 ABDOMINAL PAIN 8 0.0000
428 NEEDLE ISSUE 1 0.0000
429 DYSSTASIA 1 0.0000
430 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
431 HYPOAESTHESIA 5 0.0000
432 HEPATIC FAILURE 1 0.0000
433 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
434 OEDEMA PERIPHERAL 4 0.0000
435 EPILEPSY 1 0.0000
436 INJECTION SITE RASH 1 0.0000
437 PERIPHERAL SWELLING 5 0.0000
438 CHEST PAIN 6 0.0000
439 FEMUR FRACTURE 1 0.0000
440 INJECTION SITE ERYTHEMA 4 0.0000
441 SWELLING 3 0.0000
442 NERVOUS SYSTEM DISORDER 1 0.0000
443 PRODUCT USE ISSUE 6 0.0000
444 BONE DENSITY DECREASED 1 0.0000
445 DYSPHAGIA 3 0.0000
446 MIGRAINE 3 0.0000
447 CYSTITIS 1 0.0000
448 MOOD SWINGS 1 0.0000
449 CONTUSION 3 0.0000
450 MOVEMENT DISORDER 1 0.0000
451 HIP FRACTURE 1 0.0000
452 LACTIC ACIDOSIS 1 0.0000
453 DEEP VEIN THROMBOSIS 2 0.0000
454 DEPRESSION 7 0.0000
455 ALOPECIA 6 0.0000
456 PAIN IN EXTREMITY 9 0.0000
457 IMPAIRED HEALING 1 0.0000
458 OSTEONECROSIS 1 0.0000
459 TREMOR 5 0.0000
460 VISUAL ACUITY REDUCED 1 0.0000
461 VIRAL INFECTION 1 0.0000
462 FALL 10 0.0000
463 SYNCOPE 3 0.0000
464 SKIN DISORDER 1 0.0000
465 GAIT INABILITY 1 0.0000
466 ABDOMINAL DISCOMFORT 5 0.0000
467 SOMNOLENCE 6 0.0000
468 TYPE 2 DIABETES MELLITUS 1 0.0000
469 MALAISE 13 0.0000
470 CEREBROVASCULAR ACCIDENT 5 0.0000
471 HAEMATURIA 1 0.0000
472 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
473 NAUSEA 23 0.0000
474 DEVICE USE ERROR 1 0.0000
475 NEOPLASM PROGRESSION 1 0.0000
476 WEIGHT DECREASED 8 0.0000
477 DYSPNOEA 16 0.0000
478 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
479 PLATELET COUNT DECREASED 3 0.0000
480 DIZZINESS 14 0.0000
481 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
482 PNEUMONIA 9 0.0000
483 VOMITING 13 0.0000
484 DRUG EFFECT INCOMPLETE 1 0.0000
485 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
486 CRYING 1 0.0000
487 UNDERDOSE 2 0.0000
488 MUSCLE SPASMS 5 0.0000
489 NASOPHARYNGITIS 5 0.0000
490 INJECTION SITE MASS 1 0.0000
491 SEPSIS 3 0.0000
492 ASTHENIA 10 0.0000
493 DYSPNOEA EXERTIONAL 1 0.0000
494 ASTHMA 3 0.0000
495 RHEUMATOID ARTHRITIS 3 0.0000
496 DIARRHOEA 17 0.0000
497 DIABETES MELLITUS 2 0.0000
498 INJECTION SITE SWELLING 2 0.0000
499 HOSPITALISATION 4 0.0000
500 SEIZURE 3 0.0000
501 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
502 BACK PAIN 6 0.0000
503 PALPITATIONS 3 0.0000
504 DRUG INTERACTION 4 0.0000
505 INJECTION SITE BRUISING 2 0.0000
506 JOINT SWELLING 3 0.0000
507 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
508 CONFUSIONAL STATE 4 0.0000
509 DRY MOUTH 2 0.0000
510 DYSKINESIA 1 0.0000
511 FATIGUE 19 0.0000
512 CARDIAC ARREST 2 0.0000
513 VISUAL IMPAIRMENT 3 0.0000
514 CARDIO-RESPIRATORY ARREST 1 0.0000
515 RENAL IMPAIRMENT 2 0.0000
516 SKIN EXFOLIATION 2 0.0000
517 OSTEOARTHRITIS 1 0.0000
518 MYALGIA 4 0.0000
519 URINARY TRACT INFECTION 4 0.0000
520 HYPOACUSIS 1 0.0000
521 SEPTIC SHOCK 1 0.0000
522 COVID-19 4 0.0000
523 DRUG WITHDRAWAL SYNDROME 2 0.0000
524 COLITIS ULCERATIVE 1 0.0000
525 HEADACHE 14 0.0000
526 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
527 GASTROINTESTINAL DISORDER 2 0.0000
528 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
529 NEUTROPENIA 3 0.0000
530 SKIN IRRITATION 1 0.0000
531 NEPHROLITHIASIS 1 0.0000
532 SKIN DISCOLOURATION 1 0.0000
533 BLOOD CHOLESTEROL INCREASED 1 0.0000
534 COUGH 6 0.0000
535 OCULAR HYPERAEMIA 1 0.0000
536 DISEASE RECURRENCE 1 0.0000
537 RASH ERYTHEMATOUS 1 0.0000
538 FEELING ABNORMAL 5 0.0000
539 HYPOGLYCAEMIA 1 0.0000
540 ATRIAL FIBRILLATION 2 0.0000
541 LUNG DISORDER 1 0.0000
542 LEUKOPENIA 1 0.0000
543 HYPOTENSION 4 0.0000
544 ERYTHEMA 4 0.0000
545 ABDOMINAL PAIN UPPER 4 0.0000
546 INFLAMMATION 1 0.0000
547 PARAESTHESIA 3 0.0000
548 DEPRESSED MOOD 1 0.0000
549 HYPERTENSION 4 0.0000
550 RASH PRURITIC 1 0.0000
551 CONSTIPATION 4 0.0000
552 PAIN 11 0.0000
553 FLATULENCE 1 0.0000
554 CONVULSION 1 0.0000
555 HERPES ZOSTER 1 0.0000
556 MYOCARDIAL INFARCTION 3 0.0000
557 DYSPHONIA 1 0.0000
558 BONE PAIN 1 0.0000
559 CHILLS 2 0.0000
560 NASAL CONGESTION 1 0.0000
561 PRODUCT DOSE OMISSION ISSUE 5 0.0000
562 DISEASE PROGRESSION 2 0.0000
563 ARTHRALGIA 7 0.0000
564 CATARACT 1 0.0000
565 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
566 STOMATITIS 1 0.0000
567 ILL-DEFINED DISORDER 1 0.0000
568 VERTIGO 1 0.0000
569 DISCOMFORT 1 0.0000
570 HYPERSENSITIVITY 3 0.0000
571 EXPOSURE DURING PREGNANCY 1 0.0000
572 RASH 7 0.0000
573 LOSS OF CONSCIOUSNESS 2 0.0000
574 HYPERHIDROSIS 2 0.0000
575 PRODUCT DOSE OMISSION 1 0.0000
576 BLOOD CREATININE INCREASED 1 0.0000
577 DRY SKIN 2 0.0000
578 PRODUCT QUALITY ISSUE 2 0.0000
579 HEPATIC ENZYME INCREASED 1 0.0000
580 BURNING SENSATION 1 0.0000
581 SLEEP DISORDER 1 0.0000
582 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
583 SKIN BURNING SENSATION 1 0.0000
584 OVERDOSE 3 0.0000
585 RESPIRATORY FAILURE 1 0.0000
586 EPISTAXIS 1 0.0000
587 HALLUCINATION 1 0.0000
588 HOT FLUSH 1 0.0000
589 PRURITUS 5 0.0000
590 INJECTION SITE HAEMORRHAGE 1 0.0000
591 CARDIAC FAILURE 1 0.0000
592 THROMBOSIS 1 0.0000
593 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
594 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
595 DRUG DOSE OMISSION 2 0.0000
596 TREATMENT FAILURE 1 0.0000
597 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
598 TACHYCARDIA 1 0.0000
599 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
600 DEVICE ISSUE 1 0.0000
601 ADVERSE DRUG REACTION 1 0.0000
602 ADVERSE EVENT 1 0.0000
603 OROPHARYNGEAL PAIN 1 0.0000
604 BREAST CANCER 1 0.0000
605 CARDIAC DISORDER 1 0.0000
606 NEUROPATHY PERIPHERAL 1 0.0000
607 DEATH 9 0.0000
608 DRUG INTOLERANCE 1 0.0000
609 HEART RATE INCREASED 1 0.0000
610 CONDITION AGGRAVATED 3 0.0000
611 CHEST DISCOMFORT 1 0.0000
612 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
613 HAEMORRHAGE 1 0.0000
614 OFF LABEL USE 8 0.0000
615 DRUG INEFFECTIVE 12 0.0000
616 THROMBOCYTOPENIA 1 0.0000
617 WEIGHT INCREASED 2 0.0000
618 PSORIASIS 1 0.0000
619 RENAL FAILURE 1 0.0000
620 INFECTION 1 0.0000
621 ACUTE KIDNEY INJURY 1 0.0000
622 INJECTION SITE PAIN 2 0.0000
623 GAIT DISTURBANCE 1 0.0000
624 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
625 INCORRECT DOSE ADMINISTERED 1 0.0000
626 ANXIETY 1 0.0000